Market players are focusing on technology expansion to attain a competitive edge. DUBAI, UAE / ACCESSWIRE / February 15, 2021...
Please read the full announcement in the attached PDF Attachment 2021_07_Stock_Buybackprogram
ATLANTA, Feb. 15, 2021 (GLOBE NEWSWIRE) -- Alimera Sciences, Inc. (Nasdaq: ALIM) (Alimera), a leader in the commercialization and development...
Press release Synairgen plc(‘Synairgen’ or the ‘Company’) Synairgen announces that dosing has commenced with its inhaled interferon beta product in...
Press release Synairgen plc(‘Synairgen’ or the ‘Company’) Synairgen announces that dosing has commenced with its inhaled interferon beta product in...
This loan will further support the progress and expansion of OSE Immunotherapeutics’ lead clinical development programs in diseases with high...
ADS Offering of $20.1 million in gross proceeds closed on February 12, 2021.Biophytis’s ADSs began trading on the Nasdaq Capital...
Basel, Switzerland, February 15, 2021 Basilea Pharmaceutica Ltd. (SIX: BSLN) announced today that it has entered into an agreement to...
Press ReleaseNicox’s U.S. Licensee Eyevance Expands U.S. Promotion of ZERVIATE® In Agreement with Hikma February 15, 2021 – release at...
The Neck Hammock is a cervical traction device designed for anyone experiencing mobility problems, neck pain, and tension. It has...
GHENT, Belgium, Feb. 15, 2021 (GLOBE NEWSWIRE) -- Sequana Medical NV (Euronext Brussels: SEQUA, the “Company”), an innovator in the...
Easy-to-Implement Solution Helps Businesses, Schools, and Other Organizations Reopen Responsibly and Stay Open Safely During Infectious Illnesses IRVINE, Calif.--(BUSINESS WIRE)--Masimo...
Prime Minister, Boris Johnson visits Newcastle-based QuantuMDx - QuantuMDx has developed Q-POC™ - a rapid, PCR diagnostic device for...
CANOGA PARK, CA / ACCESSWIRE / February 13, 2021 / Research and scientific studies prove that nearly everyone on the...
Nes Ziona, Israel, Feb. 12, 2021 (GLOBE NEWSWIRE) -- Enlivex Therapeutics Ltd. (NASDAQ: ENLV), a clinical-stage macrophage reprogramming immunotherapy company...
COSELA (trilaciclib) image COSELA (trilaciclib) image - COSELA is the only FDA-approved therapy that helps proactively deliver multilineage myeloprotection to...
HOUSTON, Feb. 13, 2021 (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc., (Nasdaq:BPTH), a biotechnology company leveraging its proprietary DNAbilize® liposomal delivery...
AUSTIN, Texas, Feb. 12, 2021 (GLOBE NEWSWIRE) -- Cassava Sciences, Inc. (Nasdaq: SAVA) (the “Company” or “Cassava Sciences”), a clinical-stage...
LONDON, Feb. 12, 2021 (GLOBE NEWSWIRE) -- Autolus Therapeutics plc (Nasdaq: AUTL), a clinical-stage biopharmaceutical company developing next-generation programmed T...
DEERFIELD, Ill., Feb. 12, 2021 (GLOBE NEWSWIRE) -- Surgalign Holdings, Inc. (Nasdaq: SRGA), a global surgical implant company (the “Company”),...